Filing Details

Accession Number:
0001044321-13-000173
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-17 15:14:05
Reporting Period:
2013-12-13
Filing Date:
2013-12-17
Accepted Time:
2013-12-17 15:14:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124608 Response Genetics Inc RGDX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1044321 M David Greenhouse & W Austin Marxe C/O Special Situations Funds
527 Madison Avenue, Suite 2600
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-13 350,000 $1.17 2,953,513 No 4 S Indirect By Limited Partnerships
Common Stock Disposition 2013-12-16 3,677 $1.15 2,949,836 No 4 S Indirect By Limited Partnerships
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Limited Partnerships
No 4 S Indirect By Limited Partnerships
Footnotes
  1. This is a weighted average price.
  2. This is a joint filing by Austin W. Marxe (Marxe) and David M. Greenhouse (Greenhouse). They share voting and investment control over all securities owned by Special Situations Fund III QP, LP (QP), Special Situations Cayman Fund, L.P. (Cayman) and Special Situations Life Science Fund, LP (LS), respectively 1,055,934 shares of Common Stock are held by QP, 884,834 shares of Common Stock are held by Cayman, and 1,009,068 shares of Common Stock are held by LS. The interest of Marxe and Greenhouse in the shares of Common Stock owned by QP, Cayman and LS is limited to the extent of his pecuniary interest.